Flagship Wealth Advisors’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$202 Buy
+100
New +$277 ﹤0.01% 459

Other funds holding AVXL

Flagship Wealth Advisors's AVXL Position: Q3 2026 in Review

Flagship Wealth Advisors opened a new position in Anavex Life Sciences (AVXL) in Q3 2026: 100 shares worth $202. The stake represents ﹤0.01% of the portfolio and ranks #459 among its holdings.

162 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • Flagship Wealth Advisors held 100 shares of Anavex Life Sciences worth $202 as of Q3 2026.
  • Anavex Life Sciences was a new Flagship Wealth Advisors position in Q3 2026.
  • Anavex Life Sciences made up ﹤0.01% of Flagship Wealth Advisors's portfolio in Q3 2026, its #459 holding.
  • 162 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on Flagship Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.